Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness
Malin E. Winerdal, David H. Krantz, Ciputra Adijaya Hartana, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 5, pp. 528-538
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Sia V. Lindskrog, Frederik Prip, Philippe Lamy, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 260
The multifaceted immune regulation of bladder cancer
Anna K. Schneider, Mathieu F. Chevalier, Laurent Derré
Nature Reviews Urology (2019) Vol. 16, Iss. 10, pp. 613-630
Closed Access | Times Cited: 154
Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
Magdalene Joseph, Deborah Enting
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 99
Matrix Metalloproteinase-2-Induced Morphologic Transformation of Self-Assembled Peptide Nanocarriers Inhibits Tumor Growth and Metastasis
Juanjuan Cao, Xiaomeng Yuan, Xinyu Sun, et al.
ACS Materials Letters (2023) Vol. 5, Iss. 3, pp. 900-908
Closed Access | Times Cited: 26
Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment
Die Lv, Yujie Fei, Hongli Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer
Tino Vollmer, Stephan Schlickeiser, Leila Amini, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 576
Closed Access | Times Cited: 39
Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
Aleksandra Semeniuk-Wojtaś, Karolina Poddębniak-Strama, Magdalena Modzelewska, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 1971-1989
Open Access | Times Cited: 15
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens
Sara Wahlin, Björn Nodin, Karin Leandersson, et al.
OncoImmunology (2019) Vol. 8, Iss. 11, pp. e1644108-e1644108
Open Access | Times Cited: 37
The Tumor Microenvironment of Bladder Cancer
Ken Hatogai, Randy F. Sweis
Advances in experimental medicine and biology (2020), pp. 275-290
Closed Access | Times Cited: 37
Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer
Ann Taber, Frederik Prip, Philippe Lamy, et al.
European Urology Oncology (2022) Vol. 5, Iss. 2, pp. 203-213
Open Access | Times Cited: 19
Nucleotide variation in Foxp3 gene and prognosis of bladder cancer: a case-control study
Qin Li, Yan Zhang, Min Su, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Construction and verification of a prognostic model for bladder cancer based on disulfidptosis-related angiogenesis genes
Zhihao Zhou, Yuwei Zhang, Yuhua Zhou, et al.
PeerJ (2025) Vol. 13, pp. e18911-e18911
Open Access
Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies
Antimo Di Spirito, Sahar Balkhi, Veronica Vivona, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer
Faping Li, Hui Guo, Yishu Wang, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106641-106641
Closed Access | Times Cited: 31
lncRNA SNHG1 Promotes Basal Bladder Cancer Invasion via Interaction with PP2A Catalytic Subunit and Induction of Autophagy
Jiheng Xu, Rui Yang, Xiaohui Hua, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 354-366
Open Access | Times Cited: 31
Tumor immune microenvironment in non–muscle-invasive urothelial carcinoma of the bladder
Marie‐Lisa Eich, Alcides Chaux, Güneş Güner, et al.
Human Pathology (2019) Vol. 89, pp. 24-32
Closed Access | Times Cited: 30
High expression of EMP1 predicts a poor prognosis and correlates with immune infiltrates in bladder urothelial carcinoma
Bo Lin, Tianwen Zhang, Xin Ye, et al.
Oncology Letters (2020) Vol. 20, Iss. 3, pp. 2840-2854
Open Access | Times Cited: 28
Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
Nicole Viveiros, Bianca C. T. Flores, João Lobo, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 17
The inflammatory microenvironment and the urinary microbiome in the initiation and progression of bladder cancer
Xingxing Huang, Ting Pan, Lili Yan, et al.
Genes & Diseases (2020) Vol. 8, Iss. 6, pp. 781-797
Open Access | Times Cited: 24
Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer
Ting Xu, Weizhang Xu, Yuxiao Zheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer
Leilei Xu, Changhua Li, Hua Fu, et al.
Medical Oncology (2021) Vol. 38, Iss. 5
Closed Access | Times Cited: 17
Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome
Yiheng Du, Bo Wang, Xiang Jiang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
Mengjia Huang, Lin Liu, Junkai Zhu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 16
ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma
Shiyong Xin, Yanwei Zhang, Zhenhua Zhang, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1201-1220
Closed Access | Times Cited: 2
Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status
Stacy R. Bedore, Joshua van der Eerden, Faizan Boghani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9899-9899
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top